Concepedia

Nancy Trogani

NT

Statistics

Publications

6

Citations

948

H-Index

6

Active since

1999

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Nancy Trogani is an author at Novartis (United States) specializing in histone deacetylation, oncology, and histone deacetylases.

Publications per year

1999–2004

6

Publications

6

Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects

Lidia Sambucetti, Denise Fischer, Sonya Zabludoff et al. · Journal of Biological Chemistry · 1999 · 393 citations · Full text

, , +10

Isolation and Characterization of a Novel Class II Histone Deacetylase, HDAC10

Denise Fischer, Richard Cai, Umesh Bhatia et al. · Journal of Biological Chemistry · 2002 · 137 citations · Full text

, , +10

Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824

Peter Atadja, Lin Gao, Paul Kwon et al. · Cancer Research · 2004 · 134 citations

, , +11

<i>N</i>-Hydroxy-3-phenyl-2-propenamides as Novel Inhibitors of Human Histone Deacetylase with in Vivo Antitumor Activity:  Discovery of (2<i>E</i>)-<i>N</i>-Hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1<i>H</i>-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)

Stacy Remiszewski, Lidia Sambucetti, Kenneth W. Bair et al. · Journal of Medicinal Chemistry · 2003 · 129 citations · Full text

, , +13

Inhibitors of Human Histone Deacetylase:  Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates

Stacy Remiszewski, Lidia Sambucetti, Peter Atadja et al. · Journal of Medicinal Chemistry · 2002 · 114 citations · Full text

, , +14

1–5 of 6